Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Cancer Research

• Publication date

  1993-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8467488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of apoptosis--new targets for cancer chemotherapy.

  1992cited by this paper
• bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.

  1992cited by this paper
• bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.

  1992cited by this paper
• Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis

  1991cited by this paper
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

  1991cited by this paper
• Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.

  1991cited by this paper
• Programmed cell death in the immune system.

  1991cited by this paper
• Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia.

  1990cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper
• Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

  1990cited by this paper
• Apoptosis. The role of the endonuclease.

  1990cited by this paper
• Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

  1990cited by this paper
• bcr‐abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

  1990cited by this paper
• Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

  1990cited by this paper
• Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells.

  1990cited by this paper
• Growth control in leukemia.

  1990cited by this paper
• Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures

  1989cited by this paper
• Studies of the proliferation and differentiation of immature myeloid cells in vitro. II. Acute myelogenous leukemia

  1989cited by this paper
• Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

  1988cited by this paper
• Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene.

  1988cited by this paper
• Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene.

  1988cited by this paper

• Lyn regulates creatine uptake in an imatinib-resistant CML cell line.

  2019cites this paper
• Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia.

  2017cites this paper
• Role of Sphingolipids in Hematological Malignancies: Myeloproliferative Disorders

  2015cites this paper
• The study of homology between tumor progression genes and members of retroviridae as a tool to predict target-directed therapy failure

  2015influential citation
• The role of cytokines in governing the expansion of the T315I mutation in chronic myeloid leukaemia.

  2014cites this paper
• Enzyme responsive materials: design strategies and future developments.

  2013cites this paper
• Inhibitors of apoptosis in testicular germ cells: synthesis and biological evaluation of some novel IBTs bearing sulfonamide moiety.

  2013cites this paper
• Mexican Guidelines for the Diagnosis and Treatment of Chronic Myeloid Leukaemia

  2013cites this paper
• hematopoietic cells controls lineage programming Modulation of p210BCR-ABL activity in transduced primary human

  2013cites this paper
• Tumor malignancy is engaged to prokaryotic homolog toolbox.

  2012cites this paper
• Effect of dietary polyphenols on K562 leukemia cells: A Foodomics approach

  2012cites this paper
• Chronic myeloid leukemia

  2011cites this paper
• Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells.

  2010cites this paper
• in cell lines expressing Bcr-Abl Synergy between imatinib and mycophenolic acid in inducing apoptosis

  2010cites this paper
• Tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.

  2009cites this paper
• Proteasome inhibition in chronic myeloid leukaemia

  2009cites this paper
• Cell Cycle Regulation by Oncogenic Tyrosine Kinases in Myeloid Neoplasias: From Molecular Redox Mechanisms to Health Implications

  2008cites this paper
• Bcr-Abl-independent mechanisms of resistance to imatinib treatment in chronic myelogenous leukaemia patients

  2008cites this paper
• New Bcr-Abl-independent mechanisms ofresistance to imatinib treatment in chronicmyelogenous leukaemia patients

  2008cites this paper
• Extracellular matrix regulation of drug resistance in small-cell lung cancer

  2007cites this paper
• Stem cells in chronic myeloid leukaemia

  2007cites this paper
• Comparative proteome profiling and functional analysis of chronic myelogenous leukemia cell lines.

  2007cites this paper
• Advances in Brief WAF 1 / CIP 1 Is Induced in / ? 53-mediated G ! Arrest and Apoptosis 1

  2006cites this paper
• Perillyl Alcohol Induces c-Myc-Dependent Apoptosis in Bcr/Abl-Transformed Leukemia Cells

  2006cites this paper
• cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib

  2006cites this paper
• DESENVOLVIMENTO DE ENSAIO QUIMILUMINESCENTE BASEADO NA DETERMINAÇÃO DE FOSFATASE ALCALINA PARA DIAGNÓSTICO DIFERENCIAL ENTRE LEUCEMIA MIELÓIDE CRÔNICA E REAÇÕES

  2006cites this paper
• Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML).

  2006cites this paper
• Reflections on viruses and cancer

  2005cites this paper
• Chronic myeloid leukaemia: stem cell derived but progenitor cell driven.

  2005cites this paper
• Additive apoptotic effect of STI571 with the cytoprotective agent amifostine in K-562 cell line

  2005cites this paper
• Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.

  2005cites this paper
• Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a β1‐integrin pathway

  2004cites this paper
• Establishment and characterization of a new human erythroleukemic cell line, ERY-1.

  2004cites this paper
• Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.

  2004cites this paper
• Regulation of tumor necrosis factor-alpha induced apoptosis via posttranslational modifications in a human colon adenocarcinoma cell line

  2004cites this paper
• Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL

  2004cites this paper
• Identification of apoptotic tyrosine‐phosphorylated proteins after etoposide or retinoic acid treatment

  2004cites this paper
• Interleukin-3-mediated Cell Survival Signals Include Phosphatidylinositol 3-Kinase-dependent Translocation of the Glucose Transporter GLUT1 to the Cell Surface*

  2003cites this paper
• t(5;9)(q11;q34): a novel familial translocation involving Abelson oncogene and association with hypereosinophilia.

  2003cites this paper
• Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies

  2003cites this paper
• Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening.

  2003cites this paper
• In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.

  2002cites this paper
• Chronic leukemias and lymphomas : biology, pathophysiology, and clinical management

  2002cites this paper
• Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia

  2002cites this paper
• Ectopic expression of protein tyrosine kinase Bcr-Abl suppresses TNF-induced NF-κB activation and IκBα phosphorylation: Relationship with downregulation of TNF receptors

  2002cites this paper
• Novel targeted therapies for Bcr–Abl positive acute leukemias: beyond STI571

  2002cites this paper
• Bcr-Abl variants: biological and clinical aspects.

  2002cites this paper
• Enhanced uptake of antisense oligonucleotides using cationic liposomes and the apoptotic effect of idarubicin in K-562 cell line.

  2002cites this paper
• Modulation of p210(BCR-ABL) activity in transduced primary human hematopoietic cells controls lineage programming.

  2002cites this paper
• Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571

  2002cites this paper
• Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors.

  2002cites this paper
• Extracellular matrix regulation of drug resistance in small-cell lung cancer.

  2002cites this paper
• Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest

  2002cites this paper
• Phosphatidyl inositol signaling by BCR/ABL: opportunities for drug development

  2001cites this paper
• Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.

  2001cites this paper
• Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?

  2001cites this paper
• In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents.

  2001cites this paper
• v-Abl Protein-tyrosine Kinase Up-regulates p21WAF-1 in Cell Cycle Arrested and Proliferating Myeloid Cells*

  2001cites this paper
• Growth‐inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement

  2001cites this paper
• Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis.

  2000cites this paper
• Effect of Antisense Oligonucleotides on CD34+ Cells from Chronic Myeloid Leukemia

  2000cites this paper
• Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells

  2000cites this paper
• Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival.

  2000cites this paper
• The Survival Function of the Bcr-Abl Oncogene Is Mediated by Bad-Dependent and -Independent Pathways: Roles for Phosphatidylinositol 3-Kinase and Raf

  2000cites this paper
• Hydrogen peroxide-induced apoptosis in human hepatoma cells is mediated by CD95(APO-1/Fas) receptor/ligand system and may involve activation of wild-type p53

  2000cites this paper
• Tyrosine phosphorylation of cytoplasmic proteins in proliferating, differentiating, apoptotic HL-60 cells and blood neutrophils

  2000cites this paper
• [Antisense oligonucleotides increase the apoptotic effect of idarubicin in K-562 cell line].

  2000cites this paper
• HYDROGEN PEROXIDE INDUCES APOPTOSIS IN HUMAN HEPATOMA CELLS AND ALTERS CELL REDOX STATUS

  2000cites this paper
• E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.

  2000cites this paper
• Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase*

  2000cites this paper
• Leucémie myéloïde chronique

  1999cites this paper
• Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

  1999cites this paper
• Importance of DNA damage in the induction of apoptosis by ionizing radiation: effect of the scid mutation and DNA ploidy on the radiosensitivity of murine lymphoid cell lines.

  1999cites this paper
• Chronic myeloid leukemia.

  1999cites this paper
• Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines

  1999cites this paper
• Morphological and functional characteristics of short‐term and long‐term bone marrow cultures in chronic myelogenous leukemia

  1999cites this paper
• A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice.

  1999cites this paper
• Importance of DNA damage in the induction of apoptosis by ionizing radiation: effect of the scid mutation and DNA ploidy on the radiosensitivity of murine lymphoid cell lines.

  1999cites this paper
• Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors

  1999cites this paper
• Allogeneic Perforin-Deficient T Cells in SCID Cell Death In Vivo : Increased Expansion of A Role for Perforin in Activation-Induced T

  1998cites this paper
• Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome C can survive and maintain clonogenicity given appropriate signals to suppress apoptosis.

  1998cites this paper
• Apoptosis: basic concepts and potential significance in human cancer.

  1998cites this paper
• Anomalistic Signaling as a Possible Biochemical Explanation for Discordant Maturation in Chronic Myelogenous Leukemia (CML)

  1998cites this paper
• [Effect of granular serine proteases and protein kinases on cytolytic activity of lymphokine-activated killers].

  1998cites this paper
• Bcl-2 mRNA-targeted ribozymes: effects on programmed cell death in chronic myelogenous leukemia cell lines

  1998cites this paper
• Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells

  1998cites this paper
• Transformation of Myeloid Cells by the BCR/ABL Oncogene

  1998cites this paper
• Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors.

  1998cites this paper
• Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha

  1998cites this paper
• Oncogene Expression and Cellular Radiation Resistance: A Modulatory Role for c-myc.

  1998cites this paper
• Apoptosis in granulose cells induced by intrafollicular peptide

  1998cites this paper
• p53, mutations, and apoptosis in genistein-exposed human lymphoblastoid cells.

  1998cites this paper
• Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells

  1997influential citation
• Apoptosis: Molecular mechanisms, regulation and role in pathogenesis.

  1997cites this paper
• Role of acid/base homeostasis in the suppression of apoptosis in haemopoietic cells by v-Abl protein tyrosine kinase.

  1997cites this paper
• DOWN-MODULATION OF P210BCR/ABL INDUCES APOPTOSIS/DIFFERENTIATION IN K562 LEUKEMIC BLAST CELLS

  1997cites this paper
• Chemotherapy-induced apoptosis.

  1997cites this paper
• Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas

  1997cites this paper
• Pathways of p53-dependent apoptosis.

  1997cites this paper
• v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-XL

  1997cites this paper